175 related articles for article (PubMed ID: 38392076)
1. Randomized Double-Blind Placebo-Controlled Study of Salivary Substitute with Enzymatic System for Xerostomia in Patients Irradiated in Head and Neck Region.
Porangaba LP; de Melo Garcia F; Rabelo APAA; Andrade AP; de Abreu Alves F; Pellizzon ACA; Jaguar GC
Curr Oncol; 2024 Feb; 31(2):1102-1112. PubMed ID: 38392076
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study.
Jakobsen KK; Carlander AF; Grønhøj C; Todsen T; Melchiors J; Paaske N; Madsen AKØ; Kastrup J; Ekblond A; Haack-Sørensen M; Farhadi M; Maare C; Friborg J; Lynggard CD; von Buchwald C
Trials; 2023 Sep; 24(1):567. PubMed ID: 37658468
[TBL] [Abstract][Full Text] [Related]
3. Effect of photobiomodulation on salivary flow and composition, xerostomia and quality of life of patients during head and neck radiotherapy in short term follow-up: A randomized controlled clinical trial.
Louzeiro GC; Cherubini K; de Figueiredo MAZ; Salum FG
J Photochem Photobiol B; 2020 Aug; 209():111933. PubMed ID: 32570059
[TBL] [Abstract][Full Text] [Related]
4. Trehalose versus carboxymethylcellulose oral spray for relieving radiation-induced xerostomia in head and neck cancer patients: a randomized controlled trial.
Piboonratanakit P; Ferreira JN; Pravinvongvuthi K; Maison K; Urkasemsin G; Boonroung T; Prayongrat A; Lertbutsayanukul C; Sucharitakul J; Vacharaksa A
BMC Oral Health; 2023 May; 23(1):288. PubMed ID: 37179287
[TBL] [Abstract][Full Text] [Related]
5. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study.
Forner L; Hyldegaard O; von Brockdorff AS; Specht L; Andersen E; Jansen EC; Hillerup S; Nauntofte B; Jensen SB
Oral Oncol; 2011 Jun; 47(6):546-51. PubMed ID: 21493124
[TBL] [Abstract][Full Text] [Related]
6. Objective and subjective assessment of xerostomia in patients of locally advanced head-and-neck cancers treated by intensity-modulated radiotherapy.
Lal P; Nautiyal V; Verma M; Yadav R; Maria Das KJ; Kumar S
J Cancer Res Ther; 2018; 14(6):1196-1201. PubMed ID: 30488829
[TBL] [Abstract][Full Text] [Related]
7. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09.
Fisher J; Scott C; Scarantino CW; Leveque FG; White RL; Rotman M; Hodson DI; Meredith RF; Foote R; Bachman DG; Lee N
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):832-6. PubMed ID: 12788192
[TBL] [Abstract][Full Text] [Related]
8. Effects of an integrated supportive program on xerostomia and saliva characteristics in patients with head and neck cancer radiated with a low dose to the major salivary glands: a randomized controlled trial.
Jiang N; Zhao Y; Stensson M; Mårtensson J
BMC Oral Health; 2022 May; 22(1):199. PubMed ID: 35606811
[TBL] [Abstract][Full Text] [Related]
9. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.
Lin A; Kim HM; Terrell JE; Dawson LA; Ship JA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):61-70. PubMed ID: 12909216
[TBL] [Abstract][Full Text] [Related]
10. Impact of low-level laser therapy on hyposalivation, salivary pH, and quality of life in head and neck cancer patients post-radiotherapy.
Palma LF; Gonnelli FAS; Marcucci M; Dias RS; Giordani AJ; Segreto RA; Segreto HRC
Lasers Med Sci; 2017 May; 32(4):827-832. PubMed ID: 28258315
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled Trial.
Jakobsen KK; Carlander AF; Todsen T; Melchiors J; Paaske N; Østergaard Madsen AK; Kloch Bendtsen S; Mordhorst C; Stampe H; Kastrup J; Ekblond A; Haack-Sørensen M; Farhadi M; Maare C; Friborg J; Lynggaard CD; Werner Hauge A; Christensen R; Grønhøj C; von Buchwald C
Clin Cancer Res; 2024 May; 30(10):2078-2084. PubMed ID: 38441659
[TBL] [Abstract][Full Text] [Related]
13. The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures.
Richards TM; Hurley T; Grove L; Harrington KJ; Carpenter GH; Proctor GB; Nutting CM
Oral Dis; 2017 Oct; 23(7):990-1000. PubMed ID: 28434191
[TBL] [Abstract][Full Text] [Related]
14. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.
Riley P; Glenny AM; Hua F; Worthington HV
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012744. PubMed ID: 28759701
[TBL] [Abstract][Full Text] [Related]
16. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of photobiomodulation therapy combined with mobile health education in patients with head and neck cancer suffering from chronic xerostomia after radiotherapy: protocol for a three-arm, randomised, placebo-controlled, double-blinded study.
Lopez-Garzon M; López-Fernández MD; Ruíz-Martínez AM; Galván-Banqueri P; Lozano-Lozano M; Tovar-Martín I; Postigo-Martin P; Ariza-Vega P; Artacho-Cordón F; Fernández-Lao C; Cantarero-Villanueva I; Fernández-Gualda MÁ; Arroyo-Morales M; Ruíz-Villaverde R; Galiano-Castillo N
BMJ Open; 2024 Jan; 14(1):e078068. PubMed ID: 38267245
[TBL] [Abstract][Full Text] [Related]
18. Explorative study on quality of life in relation to salivary secretion rate in patients with head and neck cancer treated with radiotherapy.
Almståhl A; Alstad T; Fagerberg-Mohlin B; Carlén A; Finizia C
Head Neck; 2016 May; 38(5):782-91. PubMed ID: 25537660
[TBL] [Abstract][Full Text] [Related]
19. A Phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy.
Wong RK; Jones GW; Sagar SM; Babjak AF; Whelan T
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):472-80. PubMed ID: 12957259
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
